Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects

European Neuropsychopharmacology - Tập 19 - Trang 718-725 - 2009
Masaki Kato1,2, Gaku Okugawa1, Masataka Wakeno1, Yoshiteru Takekita, Shinpei Nonen3, Shinji Tetsuo3, Keiichiro Nishida1, Junichi Azuma3, Toshihiko Kinoshita1, Alessandro Serretti2
1Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan
2Institute of Psychiatry, University of Bologna, Italy
3Clinical Pharmacology and Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan